Compare SGMO & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGMO | ONL |
|---|---|---|
| Founded | 1995 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 141.5M |
| IPO Year | 2000 | 2021 |
| Metric | SGMO | ONL |
|---|---|---|
| Price | $0.18 | $3.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $7.00 | $3.00 |
| AVG Volume (30 Days) | ★ 27.1M | 355.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ 10.20 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $36,567,000.00 | ★ $147,647,000.00 |
| Revenue This Year | $107.15 | $4.10 |
| Revenue Next Year | $76.44 | $3.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 88.60 | N/A |
| 52 Week Low | $0.12 | $1.75 |
| 52 Week High | $0.77 | $3.03 |
| Indicator | SGMO | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 37.98 | 68.11 |
| Support Level | N/A | $2.43 |
| Resistance Level | $0.55 | N/A |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 34.48 | 89.71 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.